1st Quarter - Report
RYAN MACKINNON VASAPOLI AND BERZOK, LLP for GENENTECH
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues regarding follow on biologics, H.R. 5629 Pathway for Biosimilars Act; S. 1695 Biologics, Price Competition and Innovation Act of 2007
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW BERZOK | — |
| RODNEY HOPPE | — |
| JEFF MACKINNON | — |
| DOUGLAS R NAPPI | — |
| GEORGE C O'CONNOR | — |
| WILLIAM D PHILLIPS | — |
| THOMAS RYAN | — |
| JOSEPH V VASAPOLI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.